Bio-Techne Current Assets
The Current Assets of Bio-Techne (TECH) as of Sep 4, 2026 is 527.82 M USD. In the previous year, Current Assets was 608.30 M USD — a change of -13.23% (lower).
Get this data via API
Financial Data API
Current Assets
527.82 MUSD
YoY
-13.23%
Last updated:
The Bio-Techne Current Assets history
3 Years
10 Years
25 Years
Max
| YEAR | Current Assets | YoY |
|---|---|---|
| 527.82 MUSD | -13.23% | |
| 608.30 MUSD | -1.48% | |
| 617.42 MUSD | -0.66% | |
| 621.51 MUSD | +2.64% | |
| 605.51 MUSD | +18.58% | |
| 510.62 MUSD | -1.97% | |
| 520.89 MUSD | +26.23% | |
| 412.64 MUSD | +3.58% | |
| 398.37 MUSD | +14.48% | |
| 348.00 MUSD | +37.06% | |
| 253.90 MUSD | +2.28% | |
| 248.25 MUSD | -47.11% | |
| 469.41 MUSD | +14.62% | |
| 409.54 MUSD | +18.21% | |
| 346.47 MUSD | +50.34% | |
| 230.46 MUSD | +14.65% | |
| 201.00 MUSD | -21.33% | |
| 255.51 MUSD | -1.12% | |
| 258.40 MUSD | +21.39% | |
| 212.87 MUSD | +42.06% | |
| 149.84 MUSD | +11.03% | |
| 134.96 MUSD | -36.02% | |
| 210.92 MUSD | +42.25% | |
| 148.27 MUSD | +14.84% | |
| 129.12 MUSD | +3.99% | |
| 124.17 MUSD | +43.86% | |
| 86.31 MUSD | +69.57% | |
| 50.90 MUSD | -12.99% | |
| 58.50 MUSD | +46.98% | |
| 39.80 MUSD | +19.52% | |
| 33.30 MUSD | +19.78% | |
| 27.80 MUSD | +33.01% | |
| 20.90 MUSD | +39.33% | |
| 15.00 MUSD | +29.31% | |
| 11.60 MUSD | +48.72% | |
| 7.80 MUSD | +20.00% | |
| 6.50 MUSD | +22.64% | |
| 5.30 MUSD | — |
Bio-Techne Stock analysis
Frequently Asked Questions about Bio-Techne stock
Current Assets of Bio-Techne is 527.82 M USD in 2026.
Current Assets of Bio-Techne changed from 608.30 M USD to 527.82 M USD, representing a -13.23% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Assets Bio-Techne since 2006 – with annual values, charts, and detailed analysis.
Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.
Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Bio-Techne historically and in real time.
Balance Sheet — Bio-Techne
All Key Metrics — Bio-Techne
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth